Literature DB >> 1588008

CT and MRI of the brain in inherited neurometabolic disorders.

J Brismar1.   

Abstract

The incidence of many autosomal recessive neurometabolic disorders is very high in Saudi Arabia, probably as a result of the frequency of consanguineous marriages. Because our hospital is the main referral center for the entire Kingdom, we examine a large number of patients who have a wide spectrum of neurometabolic disorders. We add our experience and review the world literature. Though a specific diagnosis is radiologically possible in a few disorders, the diagnosis must always be verified biochemically. When the patient is referred from a pediatric neurologist with the diagnosis of neurometabolic disorder, the aim of the neuroradiologist is to determine the amount of brain damage present and to follow the response to given therapy. When the patient is referred with a nonspecific diagnosis, such as delayed development, the aim is to suggest the possibility of a neurometabolic disorder and to initiate further evaluation including possible therapy and genetic counseling.

Entities:  

Mesh:

Year:  1992        PMID: 1588008     DOI: 10.1177/08830738920070011611

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  3 in total

Review 1.  Magnetic resonance imaging in lactic acidosis.

Authors:  M S van der Knaap; C Jakobs; J Valk
Journal:  J Inherit Metab Dis       Date:  1996       Impact factor: 4.982

2.  Neurometabolic Diagnosis in Children who referred as Neurodevelopmental Delay (A Practical Criteria, in Iranian Pediatric Patients).

Authors:  Parvaneh Karimzadeh; Narjes Jafari; Habibeh Nejad Biglari; Sayena Jabbehdari; Simin Khayat Zadeh; Farzad Ahmad Abadi; Azra Lotfi
Journal:  Iran J Child Neurol       Date:  2016

3.  Glutaric aciduria yype 1: First reported cases in three Saudi patients.

Authors:  R Coates; M Rashed; Z Rahbeeni; S Al-Garawi; A N Al-Odaib; N Sakati; G Gascon; H Worthen; P T Ozand
Journal:  Ann Saudi Med       Date:  1994-07       Impact factor: 1.526

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.